Fei-Na Li

627 citations
59 papers · 449 indexed · h-index 12

Fei-Na Li

55 papers receiving 444 citations

Peers

Fei-Na Li
Comparison fields: 5 of 84
  • Microbiology 15
  • Pharmacology 113
  • Biotechnology 48
  • Ecology 129
  • Molecular Biology 302
Replace Paris Laskaris with:
Paris Laskaris United Kingdom
Zhou Bai-Cheng China
Fernando Hayashi Sant’Anna Brazil
C. Rodríguez United Kingdom
Joseph S. Wirth United States
Shailly Anand India
Assem Abolmaaty Egypt
Corrado Nai Germany
Mi Kyung Eom South Korea
Chantal Fernandes Portugal
Fei-Na Li relative to Paris Laskaris United Kingdom Paris Laskaris's profile →
Citations per field
00.5×8.6×
Paris Laskaris · 1×
Citations per year

Countries citing papers authored by Fei-Na Li

Since Specialization
Citations

This map shows the geographic impact of Fei-Na Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei-Na Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei-Na Li more than expected).

Fields of papers citing papers by Fei-Na Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei-Na Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei-Na Li. The network helps show where Fei-Na Li may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fei-Na Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fei-Na Li Line = papers co-authored together Fei-Na Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20251
3 20248
4 20241
5 20242
6 20240
7 202311
8 20238
9 20230
10 20233
11 20232
12 20231
13 20232
14 20233
15 20233
16 202310
17 20231
18 202238
19 20218
20 202025

About Fei-Na Li

Fei-Na Li is a scholar working on Microbiology, Pharmacology, Biotechnology, Ecology and Molecular Biology, having authored 59 papers that have together received 449 indexed citations. Recurring topics across this work include Genomics and Phylogenetic Studies (42 papers), Microbial Natural Products and Biosynthesis (29 papers), Microbial Community Ecology and Physiology (28 papers), Tuberculosis Research and Epidemiology (6 papers), Mycobacterium research and diagnosis (6 papers), Plant Pathogens and Fungal Diseases (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Plant Disease Resistance and Genetics (4 papers). The work is most often cited by research in Microbiology (15 citations), Pharmacology (113 citations), Biotechnology (48 citations), Ecology (129 citations) and Molecular Biology (302 citations). Fei-Na Li has collaborated with scholars based in China, Russia and Macao. Frequent co-authors include Cheng‐Hang Sun, Shaowei Liu, Li Tuo, Xiaohong Chen, Xiao-Rui Yan, Tao Jin, Simon Ming‐Yuen Lee, Huiwen Zheng, Yuanqiang Zou and Min Guo. Their work appears in journals such as INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, Systematic and Applied Microbiology, Antonie van Leeuwenhoek, Frontiers in Microbiology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026